XML 36 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Note 8 - Stockholders' Equity (Tables)
3 Months Ended
Sep. 30, 2019
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Weighted
Average,
September 30,
2019
   
Range,
September 30,
2019
   
Weighted
Average,
September 30,
2018
   
Range,
September 30,
2018
 
Volatility
   
-
%
   
-
%
   
70
%
 
 63%
-
76%
 
Dividend yield
   
     
     
   
 
 
 
Risk-free interest rate
   
-
%
   
-
%
   
2.73
%
 
 2.68%
-
2.78%
 
Expected term (years)
   
-
     
-
     
3.9
   
 3.4
to
4.3
 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
   
Options
   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2019
   
7,411,600
    $
1.08
     
3.1
    $
20,375
 
Granted
   
-
     
-
     
 
     
 
 
Exercised
   
     
     
 
     
 
 
Forfeited
   
     
     
 
     
 
 
Expired
   
-
     
-
     
 
     
 
 
Outstanding at September 30, 2019
   
7,411,600
    $
1.08
     
2.9
    $
-
 
Exercisable at September 30, 2019
   
7,411,600
    $
1.08
     
2.9
    $
-
 
Schedule of Nonvested Share Activity [Table Text Block]
   
Options
   
Weighted
Average
Grant-Date
Fair
Value
 
Nonvested at July 1, 2019
   
    $
 
Granted
   
-
     
-
 
Vested
   
-
     
-
 
Nonvested at September 30, 2019
   
    $
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   
Three months
ended
September 30,
2019
   
Three months
ended
September 30,
2018
 
General and administrative:
               
Change in fair value from modification of option terms
  $
-
    $
211,185
 
Change in fair value from modification of warrant terms
   
-
     
118,233
 
Fair value of stock options expensed
   
-
     
69,625
 
Total
  $
-
    $
399,043
 
                 
Research and development:
               
Change in fair value from modification of option terms
  $
-
    $
11,115
 
Change in fair value from modification of warrant terms
   
-
     
44,793
 
Fair value of stock options expensed
   
-
     
25,875
 
Total
  $
-
    $
81,783